treatment of cerebral glioblastoma-caused bruxism with mirtazapine: a case report

Clicks: 257
ID: 162529
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract Background Bruxism refers to grind or gnash the opposing rows of upper and lower molar teeth. It is important to treat bruxism as a factor that can influence sleep quality, quality of life, and mental status in patients with malignancy. Case presentation A 41-year-old male developed bruxism secondary to cerebral glioblastoma. l-dopa, gabapentin, clonazepam, clonidine, baclofen, buspirone, or propranolol were not effective. Mirtazapine, prescribed for side effects of chemotherapy, was effective for bruxism, which was disappeared within 3 weeks. Conclusions Mirtazapine was effective for treating bruxism as well as chemotherapy complications.
Reference Key
khosravi2020jatreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Mohsen Khosravi
Journal journal of archaeological research
Year 2020
DOI
10.1186/s40981-020-00329-4
URL
http://link.springer.com/article/10.1186/s40981-020-00329-4
Keywords
glioblastoma bruxism critical care first aid intensive care

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.